|
Microsoft HealthVault Connectivity Added to OmniComm’s TrialMasterTM
EDC Solution
Cutting-Edge Technology Used to Link Clinical Trial and Healthcare Data
FORT LAUDERDALE, FL--(Marketwire – 1/25/10) - OmniComm Systems,
Inc. (OTC: OMCM.OB), one of the fastest growing companies in the
electronic data capture (EDC) marketplace, today announced that the company’s TrialMaster
EDC product has connected to Microsoft HealthVault. This new functionality will
streamline the information flow by enabling health records and data stored in the
patient’s HealthVault account to be transferred into TrialMaster for inclusion with
other information gathered during clinical trial participation.
Read More
OmniComm Systems’ TrialMasterTM EDC Solution Selected for Its Reputation
for Meeting Aggressive Timelines.
Ability to meet challenges of early phase requirements drives Sponsor’s decision
Fort Lauderdale, FL, December 15, 2009 - OmniComm Systems, Inc.
(OTC: OMCM.OB), one of the fastest growing companies in the
EDC marketplace, today announced that a West Coast biopharmaceutical company, who
specializes in small molecule medicines across a number of therapeutic areas, has
selected OmniComm’s TrialMaster EDC solution for conducting a Phase I study. The
9-month, 2-site study is planning to enroll over 80 subjects.
Read More
Beardsworth® Selects OmniComm Systems’ TrialMasterTM Solution
for the Electronic Data Capture (EDC) of a Phase II Vaccine Study
Fort Lauderdale, FL, November 24, 2009 - OmniComm Systems, Inc.
(OTC: OMCM.OB), one of the fastest growing companies in the
EDC marketplace, today announced that Beardsworth, a full service contract research
organization (CRO) who specializes in difficult therapeutic areas, has selected
OmniComm’s TrialMaster EDC solution for conducting a Phase II vaccine study. The
3-year, 10-site study is planning to enroll 340 subjects. "After a careful selection
process, we chose OmniComm Systems to be our preferred EDC provider," said Michael
J. O’Brien, Beardsworth President and CEO. "OmniComm’s solid reputation, early adoption
of industry standards, and the many features and benefits the platform offers, made
it a logical choice."
Read More
OmniComm Systems Continues its Rapid Expansion by Opening a New Office in Monmouth
Junction, NJ
Fort Lauderdale, FL, November 19, 2009 - OmniComm Systems, Inc.
(OTC: OMCM.OB), one of the fastest growing companies in the
EDC and eClinical marketplace, announced today that it has opened a new office in
Monmouth Junction, NJ. The new location, situated equal distance between Princeton
and Rutgers Universities, was chosen in part for its proximity to the Route One
technology and pharmaceutical research corridor.
Read More
OmniComm’s TrialMasterTM EDC Solution Selected by Leading Medical
Device Manufacturer for Phase IV Cardiovascular Device Study
Long Term Customers Continue to Propel OmniComm’s Fast-Paced Growth
Fort Lauderdale, FL, November 17, 2009 - OmniComm Systems, Inc.
(OTC: OMCM.OB), one of the fastest growing companies in the
EDC marketplace, announced today that a leader in the medical device industry has
selected OmniComm’s TrialMaster EDC solution for the data capture of a Phase IV
cardiovascular study. The 24-months, 7-site study will enroll 100 subjects.
Read More
OmniComm Ranks Number 284 on Deloitte’s 2009 Technology Fast 500TM for Fastest
Growing Companies in North America.
Attributes its 455% Percent Revenue Growth to the superiority of its Electronic Data
Capture (EDC) solution TrialMasterTM and its "First in Customer Service”
philosophy.
Fort Lauderdale, FL, October 20, 2009 - OmniComm Systems, Inc.
(OTC: OMCM.OB)today announced that it ranked number 284 on
Technology Fast 500™, Deloitte LLP’s ranking of 500 of the fastest growing technology,
media, telecommunications, life sciences and clean technology companies in North
America. Rankings are based on percentage of fiscal year revenue growth during the
five-year period from 2004–2008. OmniComm grew 455% percent during this period.
Read More
OMNICOMM DELIVERS ITS STUDY DATA TABULATION MODEL (SDTM) EXPORT TOOL AHEAD OF
ITS PLANNED 2010 RELEASE DATE.
Fort Lauderdale, FL, October 16, 2009 - /Marketwire/ OmniComm Systems,
Inc. (OTC: OMCM.OB), one of the fastest growing companies in the
electronic data capture (EDC) marketplace, announced today that its new SDTM solution
is ready, ahead of schedule, and is available to its customers for deployment and
implementation into clinical studies. This new solution was developed for OmniComm’s
flagship EDC product, TrialMaster™ and will allow for mapping and exporting of data
directly into the CDISC SDTM format, ensuring an accelerated pathway towards electronic
submission of clinical data. OmniComm is a CDISC ODM certified and is known in the
industry for its commitment to standards and for bringing innovative eClinical solution
to the life science industry. OmniComm’s TrialMaster solution has supported the
CDISC ODM, CDASH (including naming conventions and domain structures), HL7, E2B,
and caBIG standards for years, and with the addition of CDISC SDTM, will be the
first EDC company to leverage all of the industry leading standards in a single
solution.
Read More
OMNICOMM SYSTEMS' TRIALMASTERTM ADDED TO KENDLE'S SUITE OF ECLINICAL
SOLUTIONS IN MULTI-YEAR ENTERPRISE AGREEMENT.
Fort Lauderdale, FL, September 30, 2009– /Marketwire/ -- OmniComm Systems, Inc. or the "Company" (OTC Bulletin Board:
OMCM ), one of the fastest-growing companies in the EDC
marketplace, today announced that Kendle,
a leading global clinical research organization (CRO), will add OmniComm’s TrialMaster
EDC solution to its current eClinical offerings in a multi-year enterprise-wide
agreement.
Read More
OMNICOMM SYSTEMS INC. EXPANDS ITS SUCCESSFUL CRO PREFERRED PROGRAMTM
BY SIGNING ON THREE NEW CRO PARTNERS.
Fort Lauderdale, FL, September 1, 2009 -- OmniComm Systems, Inc.
(OTC Bulletin Board: OMCM.OB ), a leader in integrated electronic data capture (EDC) solutions for clinical
trials, and one of the fastest growing companies in the EDC marketplace, announced
today that three additional clinical research organizations (CRO) have joined its rapidly
expanding partnership program, the CRO Preferred Program. The partnership allows
CROs in the program to offer their clients the flexible, intuitive and robust EDC
solution, TrialMasterTM, for clinical trials. The CRO Preferred Program’s
distinct advantages include fixed pricing with no hidden fees, complete sales and
marketing support from OmniComm, a dedicated hosted environment and comprehensive
training and support for TrialMaster.
Read More
Pleiad Devices Selects OmniComm Systems as their eClinical Solutions Provider
Fort Lauderdale, FL, August 25, 2009 -- OmniComm Systems, Inc.
(OTC Bulletin Board: OMCM.OB ), a leader in integrated electronic data capture
(EDC) solutions for clinical trials, announced today that their EDC tool, TrialMasterTM,
has been selected by Pleiad, Inc., a Cambridge, Massachusetts based Contract Research
Organization (CRO) with European operations in the U.K., to provide eClinical services
to its customers. Pleiad’s investment will provide it with the products and services
to manage two upcoming studies investigating the use of ophthalmic medical devices.
This partnership is expected to generate more than $1 million to OmniComm over the
next few years. Pleiad has worked with the TrialMaster EDC tool since April 2008
under OmniComm’s CRO Preferred Program, and is now transitioning to a Technology
Transfer model in order to provide greater value to its customers engaged in these
important clinical trials.
Read More
Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions
for International Phase III Study in Parkinson’s Disease
Fort Lauderdale, FL, August 20, 2009 -- OmniComm Systems, Inc.
(OTC Bulletin Board: OMCM.OB ), one of the fastest growing companies in the EDC
marketplace, today announced that Impax Pharmaceuticals, the brand division of Impax
Laboratories, Inc., Hayward, CA, has selected the TrialMaster EDC solution for conducting
a Phase III study in patients with Parkinson’s Disease. "While managing a global
multi site clinical trial there can be significant challenges in getting trial data
when you want it and in the format that you need it," said Suneel Gupta, PhD, Chief
Scientific Officer for Impax. "The TrialMaster EDC solution provides us with an
intuitive and easy to use export tool that simplifies the process. After considering
multiple different EDC solutions, we selected OmniComm Systems based on its customer
driven approach and reputation for delivering unparalleled service and support.
Additionally, its support of industry standards has enabled us to meet our very
tight corporate timelines for this important study."
Read More
Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for
Phase III Medical Device Study and Joins OmniComm’s CRO Preferred Program
Fort Lauderdale, FL, August 18, 2009 -- OmniComm
Systems, Inc. (OTC Bulletin Board: OMCM.OB ), a leader in integrated
electronic data capture (EDC) solutions for clinical trials, announced today that it has been selected by Amarex, a
Mid-Atlantic based Contract Research Organization (CRO) to provide eClinical solutions for an upcoming Phase III
trial investigating the use of a medical device for wound healing. The study will be conducted at over 30 sites and
will recruit up to 300 patients over the course of two years. Amarex also joins OmniComm’s CRO Preferred
Program, which will allow them to offer OmniComm’s flexible, robust electronic data capture solution, TrialMasterTM,
to their clients. Amarex also benefits from the CRO Program’s distinct advantages that include fixed pricing with no
hidden fees, complete sales and marketing support, and dedicated hosting services in OmniComm’s world class
hosting facility.
Read More
Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study
FT. LAUDERDALE, Fla., August 13, 2009 -- OmniComm
Systems, Inc. (OTC Bulletin Board: OMCM ), a leader in integrated
electronic data capture (EDC) solutions for clinical trials, today announced that it has been selected by a leading
European based Contract Research Organization (CRO) to provide eClinical solutions for a pivotal Phase III study
in rheumatoid arthritis (RA). Phase III clinical studies serve to establish the safety and efficacy of investigational
new drugs, in large patient populations, and are the last step prior to review for approval by the regulatory
authorities, such as FDA and the EMEA . This particular RA study is expected to last 48 months and enroll close to
300 patients in 20 sites located in Europe.
Read More
Major Biotechnology Company Selects OmniComm Systems to Provide eClinical Solutions for Phase I HIV Trials
FT. LAUDERDALE, Fla., August 10, 2009 /PRNewswire-FirstCall/ -- OmniComm
Systems, Inc. (OTC Bulletin Board: OMCM ), a global leader in integrated electronic data capture (EDC) solutions for clinical
trials announced today that a major West coast biopharmaceutical company has selected OmniComm to
provide eClinical solutions for two of its phase I HIV studies involving over 100 patients. Both HIV studies
are expected to run for approximately 7 months. OmniComm Systems has already done extensive work
with this client in different therapeutic areas.
Read More
OmniComm Systems Signs Licensing Deal with West Coast Clinical Research Organization<
FT. LAUDERDALE, Fla., August 6, 2009 /PRNewswire-FirstCall/ --
OmniComm Systems, Inc. (OTC Bulletin Board: OMCM ), a leader in integrated electronic data capture (EDC)
solutions for clinical trials, announced today that it has entered into a licensing
agreement with a west coast Clinical Research Organization (CRO) for the use of
ther TrialMaster™ solution in a Technology Transfer model. The agreement is expected
to generate more than $1.1 million from licensing, maintenance, hosting, and consulting
fees for OmniComm over the next three years. It also allows this leading CRO to
expand its offering to its customers to include the latest in cutting edge technologies
for electronic data capture.
Read More
OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor
- Logos Technologies, Ltd.
FT. LAUDERDALE, Fla., August 4, 2009 /PRNewswire-FirstCall/ --
OmniComm Systems, Inc. (OTC Bulletin Board: OMCM ), a leader in integrated electronic data capture (EDC)
solutions for clinical trials announced today that the company has acquired the
EDC assets of UK based, clinical software provider, Logos Technologies, Ltd. The
acquisition will be operated by OmniComm’s UK subsidiary, OmniComm Ltd. Logos’ exceptional
software is used to collect clinical trial data gathered while conducting Phase
I clinical trials. Phase I clinical trials are the first stage of the US or International
regulatory approval process, in order to get new drugs and medical devices to the
marketplace. The Logos software complements OmniComm’s TrialMaster® software, which
is primarily used in later stage clinical trials. The Logos products cover all aspects
of the Phase I process from subject recruitment and clinical workflow management
to laboratory sample management. Regular EDC solutions for later stage trials do
not include a pro-active data collection system, which is imperative for the very
time-controlled data collection during many early stage clinical studies. There
are only 3 commonly known Phase I EDC systems in the world that are capable of demonstrating
this functionality.
Read More
Growing Midwestern Clinical Research Organization Selects OmniComm Systems to
Provide eClinical Solutions for Phase IV Studies
FT. LAUDERDALE, Fla., July 30, 2009 /PRNewswire-FirstCall/ -- OmniComm
Systems, Inc. (OTC Bulletin Board: OMCM ) , a leader in integrated electronic data capture
(EDC) solutions for clinical trials announced today that a growing US Clinical Research
Organization (CRO) has selected OmniComm to provide eClinical solutions in connection
with two of the CRO’s Phase IV studies covering approximately 27 sites and more
than 700 subjects. Additional details were not disclosed. Phase IV studies take
place after a drug has been approved for marketing and are designed to provide broader
experience in evaluating the safety and effectiveness of the new medicine in larger
numbers of patients, subpopulations of patients, and to compare and/or combine it
with other available treatments.
Read More
OmniComm Systems, Inc. Retains Emerging Growth Equities, Ltd., as its
Strategic Financial Advisor
FT. LAUDERDALE, Fla., July 7 /PRNewswire-FirstCall/ -- OmniComm Systems,
Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data
capture (EDC) solutions for clinical trials announced today that its Board
of Directors has retained Emerging Growth Equities, Ltd. (EGE) as its
strategic financial advisor to assist in evaluating strategic alternatives
with a focus on acquisitions that may be available to the Company.
Read More
OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology
-- Acquisition Extends the Company’s Suite of Products and Increases
Breadth of EDC Customers --
FORT LAUDERDALE, Fla. and PHILADELPHIA, June 23 /PRNewswire-FirstCall/ --
OmniComm Systems, Inc. ® (OTC Bulletin Board: OMCM) ("OmniComm") a leader
in integrated electronic data capture (EDC) solutions for clinical trials,
and eResearchTechnology, Inc. (Nasdaq: ERES) ("ERT"), a global provider of
technology and services that enable the pharmaceutical, biotechnology, and
medical device industries worldwide to collect, interpret, and distribute
cardiac safety and clinical data, today announced that OmniComm has
acquired the EDC business of ERT.
Read More
OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice
President, Europe & Asia/Pacific
OMNICOMM CONTINUES ITS EXPANSION INTO EUROPE AND STRENGTHENS ITS SENIOR
MANAGEMENT TEAM
FT. LAUDERDALE, Fla., May 12 /PRNewswire-FirstCall/ -- OmniComm Systems,
Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data
capture (EDC) solutions for clinical trials, today announced that it has
strengthened its European presence and management team with the addition
of Dr. Wolfgang Summa. As Executive Vice President, Europe & Asia/Pacific
based in OmniComm’s Bonn, Germany facility, Dr. Summa will be focused on
the expansion of our products and services throughout Europe and the Asia
Pacific area.
Read More
clinicalprojects international GmbH Joins the OmniComm CRO Preferred
Program(TM) and Chooses TrialMaster(TM) for Electronic Data Capture (EDC)
Contract Research Organization (CRO) Selects TrialMaster(R) for EDC
FT. LAUDERDALE, Fla., April 23 /PRNewswire-FirstCall/ -- OmniComm Systems,
Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data
capture (EDC) solutions for clinical trials, today announced that
clinicalprojects international GmbH (CPI), a full service, global contract
research organization based in Rheinbach, Germany, has become a member of
OmniComm’s CRO Preferred Program. The partnership allows CPI to offer
their clients the flexible, intuitive and robust EDC solution,
TrialMaster, for clinical trials. The CRO program’s distinct advantages
include fixed pricing with no hidden fees, complete sales and marketing
support from OmniComm, a dedicated, hosted environment, and comprehensive
training and support for TrialMaster.
Read More
OmniComm Systems Announces 1st Quarter Results of Operations
FT. LAUDERDALE, Fla, April 22/PR Newswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB),
a leader in integrated eClinical solutions for the clinical trials market today announced its
results of operations for the first quarter of fiscal 2009
Read More
OMNICOMM SYSTEMS, INC. EXPERIENCES RECORD YEAR END RESULTS - $18 MILLION IN SIGNED CONTRACTS FOR THE YEAR 2008
FT. LAUDERDALE, FL – January 16, 2009 – /PR Newswire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB),
a leader in integrated electronic data capture
solutions for clinical trials, today announced record breaking results for 2008 in new and
repeat business that exceeded original expectations. A record jump of 80% in contracts
over 2007 clearly validates OmniComm’s position as a major contender in the EDC
Marketplace.
Read More
Sarah Cannon Research Institute Selects OmniComm Systems’, Electronic Data Capture Solution, TrialMasterTM, For Clinical Trials Management
FT. LAUDERDALE, FL – November 4, 2008 – /PR Newswire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated EDC solutions for clinical trials, today announced that after an extensive evaluation of the leading EDC vendors, the Sarah Cannon Research Institute (SCRI), www.sarahcannonresearch.com, has chosen to use OmniComm’s TrialMaster for their electronic data capture software and services needs. SCRI selected OmniComm for several key reasons, including TrialMaster’s functionality. However, the deciding factor was OmniComm’s responsiveness and the level of service that the company delivers, something that SCRI requires for their sites.
Read More
OmniComm Systems, Inc. Is Fueled By Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services
FT. LAUDERDALE, FL – October 29, 2008 – /PR Newswire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture solutions for clinical trials, today announced another momentous quarter for new business. Signed contracts through the first 3 quarters of 2008, totaling $15.8M, are exceeding projected expectations for the year.
Read More
OMNICOMM SYSTEMS, INC. TO PRESENT AT THE NOBLE FINANCIAL EQUITY CONFERENCE
FT. LAUDERDALE, FL – August 12, 2008 – OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that Stephen Johnson, COO, and Ronald Linares, CFO, will present at the Fourth Annual Noble Financial Equity Conference at 7:30 a.m. (Pacific) on Tuesday, August 19, 2008 at the Loews Lake Las Vegas Resort, Nevada.
Read More
OMNICOMM SYSTEMS, INC. INDUSTRY EXPERTS TO DRIVE ELECTRONIC DATA CAPTURE (EDC) SESSIONS AT UPCOMING CLINICAL RESEARCH MEETINGS
Clinical Research Veterans to conduct sessions on EDC implementation
FT. LAUDERDALE, FL – August 8, 2008 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that several of their key executives have been asked to conduct sessions on the benefits of electronic data capture and the use of effective implementation methods to maximize the potential benefits of using EDC. The sessions will be held at two of the industry’s premier meetings, The Data Monitoring Committees Conference in August in Philadelphia and the Society for Clinical Data Management Fall Conference in September in Dallas.
Read More
COLORADO PREVENTION CENTER ADOPTS ELECTRONIC DATA CAPTURE AND CHOOSES OMNICOMM SYSTEMS, INC. AS ITS PREMIER VENDOR
Academic Research Organization becomes an OmniComm CRO Preferred Program™ partner
FT. LAUDERDALE, FL – August 5, 2008 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that Colorado Prevention Center (CPC) has chosen OmniComm as their preferred provider as they move from paper data collection to EDC for their clinical trials. CPC delivers all of the traditional services of a CRO with additional emphasis on the quality of the science and trial conduction. Joining the CRO Preferred Program allows them to offer superior electronic data capture services and support to their clinical development clients worldwide.
Read More
OMNICOMM SYSTEMS, INC. INTRODUCES THE TRIALMASTER™ eLEARNING TOOL
Company augments their full service training suite, OmniLearn™, with a state-of-the-art eLearning tool
FT. LAUDERDALE, FL – August 4, 2008 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that the company introduced TrialMaster eLearning, their robust, self-paced education tool. The on-demand training module joins a comprehensive suite of training options that are a part of OmniLearn for TrialMaster. OmniLearn users can take advantage of Instructor led live training, Instructor led web-based training, Train-the-Trainer sessions, customized training packages and now eLearning. One of the company’s largest clients, a major west coast biotechnology company, is using the TrialMaster eLearning tool for 10 international studies at 427 sites worldwide.
Read More
OMNICOMM SYSTEMS, INC. HAS ANOTHER RECORD BREAKING QUARTER DELIVERING ELECTRONIC DATA CAPTURE (EDC) SOLUTIONS & SERVICES
$8.7 million in contracts are signed in Q2 2008, representing a 300% increase from Q2 last year
FT. LAUDERDALE, FL – July 7, 2008 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture solutions for clinical trials, today announced another landmark quarter for new business. This is the 3rd quarter in a row that OmniComm has surpassed its previous best quarter. Signed contracts through the first 2 quarters of 2008, totaling almost $12M, have already surpassed signed contracts from all of last year.
Read More
CITY OF HOPE, AN NCI-DESIGNATED COMPREHENSIVE CANCER CENTER, GOES LIVE USING OMNICOMM'S FIRST IN FUNCTIONALITY™, ELECTRONIC DATA CAPTURE (EDC) SOLUTION
TrialMaster™ v4 is used in a Phase I Single Agent Study of Pazopanib in Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction
FT. LAUDERDALE, FL May 22, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture solutions for clinical trials, today announced that City of Hope, a National Cancer Institute (NCI)-designated comprehensive cancer center, has gone live using TrialMaster for EDC in the first of many trials that will benefit from using a unique library of National Cancer Institute (NCI) related reusable electronic case report forms (eCRFs) developed by OmniComm and City of Hope. The trial, coordinated by City of Hope on behalf of the California Cancer Consortium, will enroll between 72 and 132 patients and will involve at least 17 participating centers, including international sites.
Read More
OMNICOMM SYSTEMS, INC. ENTERS INTO AN ENTERPRISE ELECTRONIC DATA CAPTURE (EDC) AGREEMENT WORTH $8-10 MILLION WITH A MAJOR BIOTECHNOLOGY COMPANY
Company continues to expand its footprint by providing leading-edge, integrated EDC solutions and services to its rapidly growing customer base
FT. LAUDERDALE, FL May 19, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that the company has entered into a 5-year, multi-million dollar enterprise agreement with a major west coast biotechnology company. The agreement allows the biotech company to take full advantage of OmniComm's First in Functionality™, EDC solution, TrialMaster™ for up to 10 concurrent trials per year. The biotech company will strategically utilize OmniComm's EDC application to assist in managing their global clinical trials and clinical related data. The enterprise deal includes complete licensing, services and technical support for these 10 concurrent studies. The agreement also provides for an option to exceed 10 concurrent studies per year for a predetermined ‘per study' price.
Read More
OMNICOMM SYSTEMS, INC.'S SUCCESS IN DELIVERING TOP QUALITY ELECTRONIC DATA CAPTURE (EDC) SOLUTIONS & SERVICES CONTINUES WITH YET ANOTHER STRONG QUARTER
Over $3 million in contracts are booked in Q1, representing an increase in bookings of 40% from Q1 last year.
FT. LAUDERDALE, FL April 21, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that customer momentum is building as the company continues to experience dynamic growth. OmniComm attributes its success to providing quality EDC solutions and services and partnering with innovative companies that deliver the clinical trial support services that today's drug development companies demand.
Read More
OMNICOMM SYSTEMS, INC. TO PRESENT AT AeA MICRO CAP FINANCIAL CONFERENCE
FT. LAUDERDALE, FL April 30, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that its Chief Operating Officer, Stephen Johnson, and its Chief Financial Officer, Ron Linares, will present at the AeA Micro Cap Financial Conference in Monterey, CA
Read More
CRITERIUM INC. CHOOSES OMNICOMM SYSTEMS, INC. FOR ELECTRONIC DATA CAPTURE (EDC) SOFTWARE AND SERVICES AND JOINS THE CRO PREFERRED PROGRAM™
Veteran Contract Research Organization (CRO) recommends TrialMaster™ for EDC
FT. LAUDERDALE, FL April 8, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that Criterium Inc., the full service, global, technology driven contract research organization has become a member of OmniComm's CRO Preferred Program. The partnership allows Criterium to offer their clients the flexible, intuitive and robust EDC solution, TrialMaster for clinical trials. Criterium will also benefit from the CRO program's distinct advantages that include fixed pricing with no hidden fees, complete sales and marketing support from OmniComm in the selection process, a dedicated, hosted environment and comprehensive training and support for TrialMaster.
Read More
OMNICOMM SYSTEMS, INC. AND LOGOS TECHNOLOGIES PARTNER TO PROVIDE SUPERIOR ELECTRONIC DATA CAPTURE (EDC) SOLUTIONS FOR PHASE I IV CLINICAL TRIALS
Leader in integrated EDC solutions and time tested experts in early Phase EDC join forces and integrate their systems to expand the use of EDC in Phase I-IV studies
FT. LAUDERDALE, FL April 4, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that OmniComm will partner with Logos Technologies and create an integrated solution with ALPHADAS ®, the premier electronic data capture solution designed specifically for Phase I clinical trials. The combined technologies will be available for use by customers using the TrialMaster™, First in Functionality™, EDC solution. The collaboration will allow customers that are conducting clinical research in Phase I to take advantage of a clinical study management and fully mobile electronic data capture system to capture data directly from the patient's bedside. For those clients running Phase I-IV clinical studies, the combination will unify the capture, reporting, exporting and archival of clinical data into a common, cost-effective, web-based, user-interface. The final warehouse for data may reside in SQL, Oracle Clinical® database tables or in SAS®.
Read More
OMNICOMM SYSTEMS, INC. APPOINTS STEPHEN JOHNSON AS CHIEF OPERATING OFFICER
Leader in integrated EDC solutions promotes key industry veteran to spearhead operations
FT. LAUDERDALE, FL April 3, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that Stephen Johnson has been promoted to Chief Operating Officer for OmniComm. Mr. Johnson joined the company in September 2006 as Senior Vice President of Business Development and has been promoted to roles of increasing responsibility over the last 18 months as the company has experienced record growth. Mr. Johnson most recently held the position of Executive Vice President of Business Development and Professional Services. In his new role as COO, he will be responsible for sales, marketing, professional services and clinical services and support.
Read More
Pleiad Devices Joins OmniComm's CRO Preferred Program™ And Chooses The TrialMaster™ Electronic Data Capture (EDC) Solution Exclusively For Clinical Trials
CRO and EDC companies launch partnership and deliver integrated solutions for medical device companies conducting clinical research
FT. LAUDERDALE, FL March 12, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that after extensive evaluation of the industry's leading EDC systems, Pleiad Devices has chosen OmniComm as its preferred EDC vendor. Pleiad is an international Medical Device Contract Research Organization (CRO) with offices located in Europe and the US. The company's primary focus is providing clinical trial support services for medical device companies. As part of the partnership with OmniComm, Pleiad will take full advantage of the flexible, intuitive and robust EDC solution, TrialMaster, in an upcoming ophthalmology trial.
Read More
OmniComm Systems, Inc. Experiences Banner Year End Results Delivering Electronic Data Capture (EDC) Services And Support For Clinical Trials
2007 Positions OmniComm as a Major Contender in the Electronic Data Capture Marketplace
FT. LAUDERDALE, FL - January 9, 2008 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that record growth for the company combined with international expansion and a dedicated focus on the company's support services infrastructure have positioned OmniComm as a significant player among the market leaders and a technological leader for integration with EDC related products and services.
Read More
OmniComm Systems, Inc. Is Chosen By Valeant Pharmaceuticals International For Electronic Data Capture
Major pharmaceutical company chooses the TrialMasterTM EDC solution due to a clear distinction in superior services and support
FT. LAUDERDALE, FL - January 7, 2008 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that following a rigorous evaluation of six electronic data capture vendors, OmniComm's TrialMaster software was selected by Valeant Pharmaceuticals as its first choice for EDC. The initial vendor evaluation began with six EDC companies that quickly narrowed down to two major players. TrialMaster's user-friendly, intuitive and feature rich functionality were important elements in the final decision, but OmniComm's customer referrals for superior service and customer support became the deciding factor.
Read More
QST Consultations, Ltd. Chooses OmniComm Systems, Inc. For Electronic Data Capture (EDC) In A Top 15 Pharmaceutical, Phase IV Clinical Trial
OmniComm's CRO Preferred Program™ partner chooses the TrialMaster EDC solution for a Phase IV, multi-site international allergy study
FT. LAUDERDALE, FL - December 13, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that QST Consultations, Ltd. has selected OmniComm's integrated EDC solution, TrialMasterTM, for a Phase IV, multi-site international allergy study. QST is a Contract Research Organization (CRO) that provides clinical trial support for the pharmaceutical and medical device industries. QST has successfully used TrialMaster for EDC clinical trial support in the past and has recently joined OmniComm's CRO Preferred Program.
Read More
OmniComm Systems, Inc. And City Of Hope Collaboration To Benefit Entire Cancer Research Community
EDC Company to collaborate with leading Cancer Center to
build standards-based eCRFs and make available outcome of
collaboration to other users.
FT. LAUDERDALE, FL - December 4, 2007 - /MarketWire/ -
OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader
in integrated electronic data capture (EDC) solutions for
clinical trials, today announced that City of Hope (a recent
license customer of the TrialMasterTM product suite) and OmniComm
are working together to develop a set of caDSR derived
standardized case report forms and reporting tools to support
National Cancer Institute (NCI) reporting requirements.
Read More
Cardium Therapeutics And Its Subsidary, Tissue Repair Company (TRC), Extend Their Relationship With OmniComm Systems Inc. As Their Preferred Web-Based Data Collection And Management Solution
Phase 2b clinical trial of Excellarate™ for Diabetic
Ulcers to use OmniComm's First in Functionality™ electronic data
capture (EDC) solution, TrialMasterTM
FT. LAUDERDALE, FL - November 28, 2007 - /MarketWire/ - OmniComm
Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated
electronic data capture (EDC) solutions for clinical trials, today
announced that they will provide EDC services to Tissue Repair Company
for a randomized, double-blind, placebo-controlled, comparator arm
clinical trial to evaluate the safety and efficacy of Excellarate for
the potential treatment of non-healing diabetic foot ulcers.
Read More
OmniComm Systems, Inc. Continues To Have Success In Delivering Superior Integrated Electronic Data Capture (EDC) Solutions For Clinical Trial Research In Third Quarter 2007
Company Signs An Additional 10 New Business Deals With A Combination Of New And Existing Customers To Use TrialMasterTM For Electronic Data Capture
FT. LAUDERDALE, FL - October 15, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that they have closed 10 new business deals in Q3, totaling 35 deals for the year. Key market segments for the new business include pharmaceutical companies, including 2 Top 50 pharma company deals in the mix, biotechnology companies and contract research organizations (CROs). The increase in CRO business has been the primary catalyst for growth in Q3.
Read More
OmniComm Systems, Inc. Drives Industry Discussion On
Designing Adaptive Clinical Trials
Company To Host Xtalks Webinar Featuring Dr. Mark Chang Of
Millenium Pharmaceuticals
FT. LAUDERDALE, FL - September 5, 2007 - /MarketWire/ - OmniComm
Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated
electronic data capture (EDC) solutions for clinical trials, today
announced Dr. Mark Chang, co-author of the book "Adaptive Design Methods
in Clinical Trials" and the upcoming book "Adaptive Design Theory and
Implementation Using SAS and R" will be the feature guest speaker in
this thought provoking discussion on designing Adaptive Clinical
Trials.
Read More
OmniComm Systems, Inc. Appoints 18-Year Industry
Veteran Dr. Yvonne Rollinger To Spearhead Global Clinical
Electronic Data Capture Services
Latest Hire Brings The Total To 15 Additional Industry
Experienced Executives Hired In Q2, 2007 To Support The Needs
Of The Company's Rapidly Growing Customer Base
FT. LAUDERDALE, FL - August 16, 2007 - /MarketWire/ -
OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader
in integrated electronic data capture (EDC) solutions for
clinical trials, today announced that it has strengthened its
client services and support management team with the addition
of Dr. Yvonne Rollinger. As Director of Clinical Operations
based in OmniComm's Bonn, Germany facility, Dr. Rollinger will
be responsible for leading the charge to deliver best-in-class
clinical services and client support to OmniComm's rapidly
growing base of EDC customers.
Read More
OmniComm Systems, Inc. Responds To Industry's Growing Demand For Integrated Electronic Data Capture (EDC) Solutions And Signs 15 New Deals In Second Quarter 2007
A Mix Of New And Existing Companies Choose TrialMasterTM Over Other EDC Vendors For Their Clinical Trials
FT. LAUDERDALE, FL - July 23, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that they have closed 15 new business deals in Q2, 2007. Key market segments for the new business include pharmaceutical, medical device, contract research organizations (CRO) and academic medical center customers, including a high profile Top 50 pharmaceutical company. TrialMaster will be implemented in both an ASP, fully hosted environment for the new trials and also in 2 new Technology Transfer deployments for those clients that want to bring EDC in-house.
Read More
City Of Hope Selects TrialMaster To Support Clinical Trials
OmniComm Systems, Inc. to deploy a Technology Transfer of the TrialMasterTM electronic data capture (EDC) solution for clinical data collection
FT. LAUDERDALE, FL - July 11, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced that City of Hope has selected OmniComm's EDC solution, TrialMaster and has entered into negotiations on the contract to support its clinical trials, including Principal Investigator initiated and federally funded trials. City of Hope also plans to utilize the OmniComm solution to provide EDC capabilities for the California Cancer Consortium which is comprised of City of Hope, UC Davis Cancer Center, University of Southern California/Norris Comprehensive Cancer Center, University of Pittsburgh Cancer Institute and affiliated sites.
Read More
Pharmatech, Inc. Selects OmniComm Systems, Inc. As Its Preferred Electronic Data Capture (EDC) Vendor And Enters Into A Strategic Partnership To Co-Develop Next Generation Solutions For Improving Patient Accrual
CRO and EDC companies team up to co-develop a Patient Repository Solution for improving patient accrual for their physicians conducting clinical trial research.
FT. LAUDERDALE, FL - July 2, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that it will partner with Pharmatech, Inc., a Research Management Organization (RMO), to build a patient registry database that will improve patient accrual in clinical trials. The database will leverage the data mining functionality inherent in OmniComm's First in Functionality™ TrialMasterTMEDC solution to facilitate the screening and identification of patient candidates for cutting-edge oncology research. OmniComm will be the exclusive choice for Pharmatech and their network physicians who utilize EDC for clinical trials. Pharmatech will begin using TrialMaster in a multi-center, Phase II clinical trial for advanced Non-Small Cell Lung Cancer (NSCLC).
Read More
OmniComm Systems, Inc. Appoints Fernando Montero To Its Board Of Directors
FT. LAUDERDALE, FL - June 18, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC market place, today announced the appointment of Fernando Montero to its Board of Directors.
Mr. Montero, who will chair the Board's Audit Committee, has spent many years in various senior financial, operations and executive management positions.
Read More
OmniComm Systems, Inc. Completes Integration Of Their Electronic Data Capture Solution (EDC), TrialMasterTM, With The Industry Leading Clinical Data Management System (CDMS), Oracle Clinical
Integration allows customers of OmniComm Systems’ TrialMaster and Oracle Clinical to implement a solution that supports electronic and paper-based data collection in a unified solution for clinical research
FT. LAUDERDALE, FL – June 15, 2007 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC market place, today announced that it has completed Phase II of their integration project with the industry’s leading Clinical Data Management System for paper-based data collection. OmniComm released Phase I of their integration several months ago, which allows customers using TrialMaster to generate a data export in Oracle Clinical standard format that can be imported into Oracle Clinical. The integration makes it possible for companies using Oracle Clinical to store all of their EDC trial data in the same database as their paper-based data.
Read More
Pharmaceutical And Life Sciences Executive Ken Light Joins OmniComm Systems, Inc. As Senior Vice President Of Professional Services
Senior healthcare executive poised to spearhead electronic data capture (EDC) technology transfer services for government institutions and leading pharmaceutical, biotechnology, medical device and CRO companies
FT. LAUDERDALE, FL – June 13, 2007 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that, effective July 9, 2007, Ken Light will be joining OmniComm’s management team and will be responsible for leading the delivery of technology transfer and implementation services for customers seeking on-site adoption of EDC technology.
Read More
OmniComm Systems, Inc. Wins A Phase II, Multi-Center International Clinical Trial For A Major West Coast Biopharmaceutical Company
Electronic Data Capture (EDC) company poised to deliver
hosted EDC services for the first in a series of clinical trials
for this industry leader
FT. LAUDERDALE, FL – June 11, 2007 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC market place, today announced that it has begun working with a multi-billion dollar West Coast global pharmaceutical company on a Phase II, multi-center study. OmniComm’s subsidiary in Europe, OmniComm Europe GMBH located in Bonn, Germany will provide full ASP hosted support and services for the duration of the trial.
Read More
OmniComm Systems, Inc. Expands Internationally
And Launches Office In Bonn, Germany
Electronic data capture (EDC) company opens additional European
location to support international and US clients conducting global
clinical trials
FT. LAUDERDALE, FL – June 7, 2007 – /MarketWire/ -
OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest
growing companies in the EDC market place, today announced that
it has opened OmniComm Europe GMBH in Bonn, Germany. OmniComm is
expanding its global presence to support the increase in clinical
trials being conducted by their clients internationally. The Bonn
office will provide enhanced local project management and study
build activities, along with sales & marketing and local language
Help Desk support.
Read More
OmniComm Systems, Inc. Successfully Integrates Their TrialMaster
Electronic Data Capture (EDC) Solution With The National Cancer
Institute's Cancer Data Standards Repository
EDC solution's integration creates pre-populated global library
of NCI developed metadata for customers conducting NCI sponsored
clinical trials
FT. LAUDERDALE, FL May 15, 2007 /MarketWire/ - OmniComm Systems,
Inc. (OTC Bulletin Board: OMCM), one of the fastest growing
companies in the EDC marketplace, today announced that it has
completed the first commercial integration of an EDC solution with
the NCI's Center for Bioinformatics (NCICB) cancer Data Standards
Repository (caDSR). This integration allows customers conducting
cancer research to take full advantage of pre-populated global
libraries of NCI-developed metadata for their clinical trials.
Read More
|
